Current Pharmaceutical Design
Volume 28, 46 Issues, 2022
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Contents
Current Pharmaceutical Design , Volume 20 - Number 42
Editorial
Editorial (Thematic Issue: Combined Cancer Therapy)
, 20(42): 6511 - 6512Jasminka Pavelic
DOI: 10.2174/1381612820666140826154834
Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer
, 20(42): 6513 - 6521Cristina Fillat, Maria Victoria Maliandi, Ana Mato-Berciano and Ramon Alemany
DOI: 10.2174/1381612820666140826152420
Anti-Metastatics: An Overview of Drug Candidates in Current Pipelines
, 20(42): 6522 - 6528Anne Schaap-Nutt, Dane A. Thyssen, David W. Drell and Frank Entschladen
DOI: 10.2174/1381612820666140826152610
Oxidative Stress and Antioxidants in Carcinogenesis and Integrative Therapy of Cancer
, 20(42): 6529 - 6542Lidija Milkovic, Werner Siems, Renate Siems and Neven Zarkovic
DOI: 10.2174/1381612820666140826152822
Attacking c-Myc: Targeted and Combined Therapies for Cancer
, 20(42): 6543 - 6554Huilin Huang, Hengyou Weng, Hui Zhou and Lianghu Qu
DOI: 10.2174/1381612820666140826153203
The Exploitation of Toll-like Receptor 3 Signaling in Cancer Therapy
, 20(42): 6555 - 6564Tanja Matijevic Glavan and Jasminka Pavelic
DOI: 10.2174/1381612820666140826153347
NCRNA Combined Therapy as Future Treatment Option for Cancer
, 20(42): 6565 - 6574Cornelia Braicu, Cristina Catana, George A. Calin and Ioana Berindan-Neagoe
DOI: 10.2174/1381612820666140826153529
Combined Cancer Therapy: Strategies to Overcome Acquired Aromatase Inhibitor Resistance
, 20(42): 6575 - 6583Susan B. Kesmodel, Gauri J. Sabnis, Saranya Chumsri and Angela M.H. Brodie
DOI: 10.2174/1381612820666140826153711
Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
, 20(42): 6584 - 6643Roger Gilabert-Oriol, Alexander Weng, Benedicta von Mallinckrodt, Matthias F. Melzig, Hendrik Fuchs and Mayank Thakur
DOI: 10.2174/1381612820666140826153913
A Comprehensive Review of Poorly Differentiated Neuroendocrine Carcinomas (pdNECs): a Niche to Find Novel Opportunities
, 20(42): 6644 - 6651Pablo Reguera, Ainhoa Madariaga and Enrique Grande
DOI: 10.2174/1381612820666140826154033
Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease
, 20(42): 6660 - 6669Davide Melisi, Lorenzo Calvetti, Melissa Frizziero and Giampaolo Tortora
DOI: 10.2174/1381612820666140826154327
Mechanism-based Combinations with Pim Kinase Inhibitors in Cancer Treatments
, 20(42): 6670 - 6681Qingshan Yang, Lisa S. Chen and Varsha Gandhi
DOI: 10.2174/1381612820666140826154451
Curcumin in Combined Cancer Therapy
, 20(42): 6682 - 6696Koraljka Gall Troselj and Renata Novak Kujundzic
DOI: 10.2174/1381612820666140826154601
Combined Modality Therapy in Pancreatic Adenocarcinoma: Review and Updates on a Controversial Issue
, 20(42): 6697 - 6701Ludimila Cavalcante, David P. Kelsen and Kenneth H. Yu
DOI: 10.2174/1381612820666140826154724
Molecular Mechanisms Involved in the Control of Neurohypophyseal Hormones Secretion
, 20(42): 6702 - 6713M. Iovino, E. Guastamacchia, V.A. Giagulli, B. Licchelli, E. Iovino and V. Triggiani
DOI: 10.2174/1381612820666140905150730
The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
, 20(42): 6714 - 6722Feng Wang, Junsheng Lin and Ruian Xu
DOI: 10.2174/1381612820666140929100735
Editor-in-Chief
Alessandro Antonelli
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)
Biography
(12,288 citations)
Department of Clinical and Experimental Medicine
Laboratory of Primary Human Cells
University of Pisa
Pisa
Biography
Biography of Alessandro Antonelli
Alessandro Antonelli (Professor of Internal Medicine, MD) is Director of the Immuno-Endocrine
Section of Internal Medicine, and Head of the Laboratory of Primary Human Cells, University of
Pisa. His principal areas of expertise are autoimmune thyroid disorders, type 1 diabetes, systemic
autoimmune disorders, chemokines and cytokines, HCV-associated thyroid disorders and thyroid
cancer. His researches have been published in more than 370 articles on International journals
(Impact Factor > 1600; HI=75). He serves as an editorial board member and is Referee and
Reviewer of many scientific International journals.
Nobel Laureate on Editorial Board
Andrew V. Schally
(USA)
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995. Prof. Alessandro Antonelli serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net